GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM Tags Biguanide Continuous glucose monitoring (CGM) DPP-4 inhibitors GLP-1 agonists Hypoglycemia Long acting Sulphonylureas hBA1c Read more about GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM
Best Drug for GDM? Outcomes Differ Across Classes Tags Sulphonylureas GLP-1 agonists Biguanide SGLT-2 Inhibitor Read more about Best Drug for GDM? Outcomes Differ Across Classes
Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM Tags hBA1c Sulphonylureas DPP-4 inhibitors Biguanide Read more about Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM
GLP-1 Therapy Shows Fewer Parkinson Disease Cases Than Sulfonylureas Tags Sulphonylureas GLP-1 agonists Read more about GLP-1 Therapy Shows Fewer Parkinson Disease Cases Than Sulfonylureas
Triple FDC Improved HbA1c More Than Dual Therapies in T2DM Tags hBA1c Sulphonylureas Biguanide α-Glucosidase inhibitors Read more about Triple FDC Improved HbA1c More Than Dual Therapies in T2DM
GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM Tags Sulphonylureas GLP-1 agonists DPP-4 inhibitors Thiazolidinediones Read more about GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM
A Case of Hyperosmolar Hyperglycemic State With Acute Kidney Injury and Subsequent Hypoglycemia Tags Hyperglycemia hyperosmolar state Hypoglycemia hBA1c Insulin syringes Sulphonylureas Biguanide Read more about A Case of Hyperosmolar Hyperglycemic State With Acute Kidney Injury and Subsequent Hypoglycemia
MACE, Hypoglycemia Risks Differ Among Sulfonylureas Tags Coronary artery disease Hypoglycemia Sulphonylureas Read more about MACE, Hypoglycemia Risks Differ Among Sulfonylureas